Testosterone Replacement Archives

Blue Water Acquisition Announces Merger Agreement with Clarus Therapeutics

Androgens, Business, Investors, Mergers, Metabolic Therapies, Nasdaq, Shareholders, Testosterone Replacement Therapy (TRT), Therapeutics

Clarus Therapeutics Inc. and Blue Water Acquisition Corp. on April 27 announced a definitive business combination agreement that will result in Clarus becoming a publicly traded company.

For years, you’ve been replacing your patient’s testosterone. Maybe it’s time to consider replacing how it’s delivered.

Brands, Harris Poll, Hypogonadism, Oral Therapy, Patient Adherence, Testosterone, Testosterone Replacement Therapy (TRT), Therapeutics, United States

For years, you’ve been replacing your patient’s testosterone. Maybe it’s time to consider replacing how it’s delivered. While there have been frequent, and prominent, new products developed for treating hypogonadism […]

U.S. court voids $448 million award against AbbVie, but revives FTC claim over AndroGel

Blockbusters, Business, Court Rulings, FTC, Generics, Lawsuits, Partnerships, Testosterone Replacement, Therapeutics

A federal appeals court threw out an order requiring AbbVie Inc. and a partner to disgorge $448 million in profit for trying to keep generic versions of the blockbuster testosterone replacement drug AndroGel off the market.